Executive Board 134

Today the Executive Board of the World Health Organisation (WHO) discussed the issue of substandard/spurious/falsely labelled/falsified/counterfeit (SSFFC) medical products. Counterfeit medicines threaten health systems worldwide. Many countries stressed the need for enhanced regulatory capacity to be achieved, in particular, by fostering regulatory convergence. During her opening address on Monday 20 Read more…

USAID Extends Promoting the Quality of Medicines Programme

Fight the Fakes Partner USP has announced their continued partnership with USAID, Promoting Quality Medicines (PQM), through September 2019.  The PQM programme provides technical assistance to countries without national regulation of medicines to combat the availability of counterfeit drugs. This initiative promotes the introduction of new technologies, such as Pharmacheck, Read more…